Empirical Finance’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
5,127
+35
| +0.7% | +$9.03K | 0.07% | 245 |
|
|
2025
Q1 | $1.14M | Buy |
5,092
+131
| +3% | +$29.3K | 0.07% | 251 |
|
|
2024
Q4 | $1.13M | Sell |
4,961
-48
| -1% | -$11K | 0.07% | 244 |
|
|
2024
Q3 | $1.22M | Buy |
5,009
+99
| +2% | +$24.2K | 0.07% | 246 |
|
|
2024
Q2 | $940K | Sell |
4,910
-322
| -6% | -$61.6K | 0.06% | 277 |
|
|
2024
Q1 | $1.04M | Buy |
5,232
+179
| +4% | +$35.4K | 0.06% | 274 |
|
|
2023
Q4 | $869K | Buy |
5,053
+39
| +0.8% | +$6.71K | 0.06% | 284 |
|
|
2023
Q3 | $741K | Buy |
5,014
+494
| +11% | +$73K | 0.05% | 295 |
|
|
2023
Q2 | $988K | Buy |
4,520
+542
| +14% | +$118K | 0.08% | 239 |
|
|
2023
Q1 | $871K | Buy |
3,978
+202
| +5% | +$44.2K | 0.08% | 244 |
|
|
2022
Q4 | $786K | Buy |
3,776
+315
| +9% | +$65.6K | 0.08% | 249 |
|
|
2022
Q3 | $756K | Buy |
3,461
+584
| +20% | +$128K | 0.09% | 216 |
|
|
2022
Q2 | $603K | Buy |
2,877
+157
| +6% | +$32.9K | 0.08% | 239 |
|
|
2022
Q1 | $660K | Buy |
2,720
+307
| +13% | +$74.5K | 0.07% | 242 |
|
|
2021
Q4 | $629K | Buy |
2,413
+669
| +38% | +$174K | 0.07% | 243 |
|
|
2021
Q3 | $460K | Buy |
1,744
+114
| +7% | +$30.1K | 0.07% | 274 |
|
|
2021
Q2 | $402K | Buy |
1,630
+258
| +19% | +$63.6K | 0.07% | 281 |
|
|
2021
Q1 | $292K | Hold |
1,372
| – | – | 0.05% | 270 |
|
|
2020
Q4 | $292K | Buy |
+1,372
| New | +$292K | 0.05% | 270 |
|